Scheme

DSP Healthcare Fund

Holds 31 companies worth ₹3,457 Cr in Sept 2026.

Fund house
DSPThe fund house that runs this scheme.
AUM
₹3,750 CrDSP Healthcare Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 2.2% on Aug 2026, ₹3,835 Cr.
Largest holding
IPCA Laboratories LimitedIPCA Laboratories Limited is 8.1% of this scheme's NAV.
Fund manager
Chirag DagliRuns it since 1 Dec 2020, as the fund house dates it.

Holdings^{(Dec 2018 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	31 companies ·	₹ Cr
	IPCA Laboratories Limited	305
	Sun Pharmaceutical Ind Ltd	279
	Cipla	269
	Sai Life Sciences Limited	244
	Gland Pharma Limited	231
	Apollo Hospitals Enterprise Limited	228
	Globus Medical Inc	193
	Alkem Laboratories Limited	178
	Divi s Laboratories Limited	156
	Cohance Lifesciences Limited	142
	Alembic Pharmaceuticals Limited	119
	Kovai Medical Center and Hospital Limited	106
	Pfizer	102
	Concord Biotech Limited	101
	Procter Gamble Health Limited	88.6
	Vijaya Diagnostic Centre Limited	88.5
	Indoco Remedies	84.9
	Intuitive Surgical	73.3
	Thyrocare Technologies Ltd	71.6
	Manipal Health Enterprises Ltd	69.4
	Unichem Laboratories	61.6
	Syngene International Limited	50.6
	Nephrocare Health Services Ltd	41.9
	ICICI Lombard General Insurance Co	38.4
	Aarti Drugs Limited	36.7
	Abbott Laboratories	30
	Eris Lifesciences Limited	26.9
	Jupiter Life Line Hospitals Limited	13.1
	GRAIL Inc	11.8
	Abbott India Limited	9.9
	Laxmi Dental Limited	5.4

IPCA Laboratories Limited
Sun Pharmaceutical Ind Ltd

Market value of each ticked company in DSP Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	IPCA Laboratories Limited	Sun Pharmaceutical Ind Ltd
Sept 2025	₹227 Cr	₹245 Cr
Oct 2025	₹216 Cr	₹260 Cr
Nov 2025	₹247 Cr	₹281 Cr
Dec 2025	₹241 Cr	₹264 Cr
Jan 2026	₹250 Cr	₹245 Cr
Feb 2026	₹259 Cr	₹267 Cr
Mar 2026	₹272 Cr	₹270 Cr
Apr 2026	₹260 Cr	₹278 Cr
May 2026	₹259 Cr	₹276 Cr
Jun 2026	₹289 Cr	₹286 Cr
Jul 2026	₹296 Cr	₹306 Cr
Aug 2026	₹335 Cr	₹305 Cr
Sept 2026	₹305 Cr	₹279 Cr

Fig. 1.Market value of each ticked company in DSP Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Large Cap	4	24.86

Mid Cap	4	14.16

Small Cap	18	43.08

Foreign	4	8.21

Unlisted	1	1.85

Cash & others		7.84

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	15.8L	305	8.13
Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	15.4L	279	7.44
Cipla	Equity	Pharmaceuticals & Biotechnology	20L	269	7.18
Sai Life Sciences Limited	Equity	Pharmaceuticals & Biotechnology	16L	244	6.52
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	7.95L	231	6.15
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	2.79L	228	6.07
Globus Medical Inc	Equity	Healthcare Equipment & Supplies	2.69L	193	5.15
Alkem Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	3.45L	178	4.75
Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	1.68L	156	4.17
Cohance Lifesciences Limited	Equity	Pharmaceuticals & Biotechnology	32L	142	3.79
Alembic Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	14.4L	119	3.18
Kovai Medical Center and Hospital Limited	Equity	Healthcare Services	1.77L	106	2.83
Pfizer	Equity	Pharmaceuticals & Biotechnology	2.64L	102	2.72
Concord Biotech Limited	Equity	Pharmaceuticals & Biotechnology	7.36L	101	2.70
Procter Gamble Health Limited	Equity	Pharmaceuticals & Biotechnology	1.59L	88.6	2.36
Vijaya Diagnostic Centre Limited	Equity	Healthcare Services	6.16L	88.5	2.36
Indoco Remedies	Equity	Pharmaceuticals & Biotechnology	32.5L	84.9	2.26
Intuitive Surgical	Equity	Healthcare Equipment & Supplies	18.8K	73.3	1.95
Thyrocare Technologies Ltd	Equity	Healthcare Services	13.4L	71.6	1.91
Manipal Health Enterprises Ltd	Equity	Healthcare Services	9.8L	69.4	1.85
Unichem Laboratories	Equity	Pharmaceuticals & Biotechnology	11.3L	61.6	1.64
Syngene International Limited	Equity	Healthcare Services	13.9L	50.6	1.35
Nephrocare Health Services Ltd	Equity	Healthcare Services	6.35L	41.9	1.12
ICICI Lombard General Insurance Co	Equity	Insurance	2.41L	38.4	1.02
Aarti Drugs Limited	Equity	Pharmaceuticals & Biotechnology	8.52L	36.7	0.98
Abbott Laboratories	Equity	Healthcare Equipment & Supplies	31.6K	30	0.80
Eris Lifesciences Limited	Equity	Pharmaceuticals & Biotechnology	2.26L	26.9	0.72
Jupiter Life Line Hospitals Limited	Equity	Healthcare Services	5.17L	13.1	0.35
GRAIL Inc	Equity	Healthcare Services	8.73K	11.8	0.31
Abbott India Limited	Equity	Pharmaceuticals & Biotechnology	3.66K	9.9	0.26
Laxmi Dental Limited	Equity	Healthcare Equipment & Supplies	2.8L	5.4	0.14

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.